The role of macrophage podosomes in Ebola virus pathogenesis

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R21AI151717-01A1

Grant search

Key facts

  • Disease

    Ebola
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $297,000
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    ASSISTANT PROFESSOR Olena Shtanko
  • Research Location

    United States of America
  • Lead Research Institution

    TEXAS BIOMEDICAL RESEARCH INSTITUTE
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

PROJECT SUMMARY Ebola virus (EBOV) is an emerging, highly pathogenic virus associated with increasingly more frequent outbreaks of hemorrhagic disease in human populations. Approved countermeasures to prevent or treat EBOV disease are currently limited. Macrophages are the initial cells targeted by EBOV, and yet, little is known about the exact nature of EBOV-macrophage surface interactions and subsequent uptake into the cell. Due to their migratory properties, macrophages are also believed to rapidly disseminate the virus to distant tissues and organs despite the lack of experimental evidence. We have preliminary data showing that EBOV depends on podosomes, mechanosensitive adhesive structures used by macrophages to migrate through tissues and sample antigens, to enter macrophages. The data also shows that EBOV replication increases macrophage locomotion through a fibrillar 3D matrix and reduces podosome number, suggesting that the virus actively transforms infiltration of tissues by these cells. This proposal aims to examine the interactions between EBOV and podosomes. In Aim 1, we will determine whether podosomes serve as ports for EBOV entry into human macrophages. In Aim 2, we will characterize migratory and invasive properties of macrophages challenged with EBOV. In Aim 3, we will assess host resistance to systemic infection with EBOV in a mouse model of EBOV disease devoid of functional macrophages. Our findings will establish a new model of interactions between EBOV and macrophages, laying the groundwork for further investigations into pathogenesis of filoviruses. Importantly, these discoveries may lead to new areas of development of novel countermeasures targeting EBOV and related viruses.